Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

The Food and Drug Administration (FDA) is reclassifying the device type, tissue adhesive for the topical approximation of skin, from class III (premarket approval) into class II (special controls). Tissue adhesives for nontopical uses remain in class III and continue to require premarket approval applications (PMAs). FDA is proposing this

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

The Food and Drug Administration (FDA) is proposing to reclassify the full field digital mammography (FFDM) system from class III (premarket approval) to class II (special controls). The device type is intended to produce full field digital xray images of the breast. Elsewhere in this issue of the Federal Register, FDA is announcing the

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

The Food and Drug Administration (FDA) is issuing for public comment the recommendation of the Circulatory System Devices Panel (the Panel) to reclassify Percutaneous Transluminal Coronary Angioplasty (PTCA) catheters, other than cutting/scoring PTCA catheters, from class III (premarket approval) to class II (special controls). The Panel made this

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled ``Class II Special Controls Guidance Document: Full Field Digital Mammography System.'' This draft guidance document describes a means by which the full field digital mammography (FFDM) system may comply with the requirement of special controls for

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

Correction: This notice was published in the Federal Register on May 22, 2008, Volume 73, Number 100, page 29759. The Committee will now convene as follows:

June 5, 2008

10 a.m.12 p.m.: CDC, Auditorium A, Building 19, 1600 Clifton Road, NE., Atlanta, Georgia 30333.

1 p.m.5 p.m.: CDC, Room 247248, Building 19, 1600 Clifton Road, NE.,

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention

The Food and Drug Administration (FDA) is announcing the availability of the draft guidance for industry and FDA staff entitled ``Class II Special Controls Guidance Document for Certain Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters.'' The draft guidance was developed as the special controls to support the reclassification of PTCA

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Medicare & Medicaid Services

The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled ``Class II Special Controls Guidance Document: Tissue Adhesive for the Topical Approximation of Skin.'' This guidance document describes a means by which tissue adhesive for the topical approximation of skin may comply with the requirement of special

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Medicare & Medicaid Services

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Notice is hereby given that the meeting notice which we previously published in the Federal Register on May 20, 2008 (73 FR 2914029141) concerning the workshop to be held on Monday, July 7th and Tuesday, July 8th, 2008 at the Marriott Gaithersburg Washingtonian Center Hotel in Gaithersburg, Maryland 20878, contained an error. The contact email

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH), will publish periodic summaries of proposed projects to the Office of Management

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

The inventions listed below are owned by an agency of the U.S. [[Page 30953]]
Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 26, 2008, 1 p.m. to June 26, 2008, 3 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on May 16, 2008, 73 FR 2848928490.

The meeting will be held June 24,

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 23, 2008, 8 a.m. to June 24, 2008, 5 p.m., Sir Francis Drake Hotel, 450 Powell Street, San Francisco, CA 94102 which was published in the Federal Register on May 16, 2008, 73 FR 2848928490.

The meeting will be held one day only

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 17, 2008, 1 p.m. to June 17, 2008, 3 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on May 15, 2008, 73 FR 2812128122.

The meeting will be held June 20,

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Notice is hereby given of the cancellation of the Neurotechnology Study Section, June 3, 2008, 8 a.m. to June 4, 2008, 5 p.m., Grand Hyatt, 345 Stockton Street, San Francisco, CA
[[Page 30955]]
94108 which was published in the Federal Register on May 15, 2008, 73 FR 2812128122.

The meeting was cancelled due to a lack of quorum.

Dated:

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 2, 2008, 8 a.m. to June 2, 2008, 11:30 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on May 15, 2008, 73 FR 2812128122.

The meeting title has been

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention, announces the following meeting for the aforementioned subcommittee:

Time and Date: 9 a.m.5 p.m., June 10, 2008.

Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, Kentucky 41018.

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 24, 2008, 1 p.m. to June 24, 2008, 3 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on May 16, 2008, 73 FR 2848928490.

The meeting will be held June

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

The Food and Drug Administration (FDA) is proposing to amend its regulations concerning the format and content of the ``Pregnancy'', ``Labor and delivery'', and ``Nursing mothers'' subsections of the ``Use in Specific Populations'' section of the labeling for human prescription drug and biological products. The agency is proposing to require that

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

The Food and Drug Administration (FDA) has determined the regulatory review period for LUCENTIS and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of patents which claim

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration